|

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

RECRUITINGSponsored by Vanderbilt-Ingram Cancer Center
Actively Recruiting
SponsorVanderbilt-Ingram Cancer Center
Started2003-12
Est. completion2027-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT00898313

Summary

RATIONALE: Using samples of blood, urine, sputum, and lung tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular predictors of cancer in patients at high risk of lung cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

-All adults referred to Vanderbilt Medical Center, Veterans Administration Medical Center, St. Thomas Hospital and Meharry Medical Center for evaluation of signs or symptoms of lung cancer.

Exclusion Criteria:

* Inability to provide informed consent
* Minors
* Pregnant women

Conditions2

CancerLung Cancer

Locations2 sites

Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37212
VICC Clinical Trials Information Program800-811-8480cip@vanderbilt.edu
Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, 37212
Research Office615-873-8066

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.